Gsk (GSK) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Gsk (GSK) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | -31.69% |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | -26.81% |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.78% |
| Mar 31, 2026 | 55.63% |
| Dec 31, 2025 | 44.72% |
| Sep 30, 2025 | 43.96% |
| Jun 30, 2025 | 41.84% |
| Mar 31, 2025 | 32.00% |
| Dec 31, 2024 | 84.39% |
| Sep 30, 2024 | -4.70% |
| Jun 30, 2024 | -6.81% |
| Mar 31, 2024 | 40.44% |
| Dec 31, 2023 | 32.57% |
| Sep 30, 2023 | -35.13% |
| Jun 30, 2023 | -15.46% |
| Mar 31, 2023 | -63.88% |
| Dec 31, 2022 | -55.06% |
| Sep 30, 2022 | 42.33% |
| Jun 30, 2022 | -5.53% |
| Mar 31, 2022 | -111.44% |
| Dec 31, 2021 | -57.49% |
| Sep 30, 2021 | 24.45% |